Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 02.11.2026 FKU IE00B8X9NZ57 183,918.00 GBP 8,320,495.34 45.240 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 02.11.2026 FKUD IE00BD9N0445 118,238.00 GBP 3,679,101.80 31.116 ...
-
Businesses Optimistic About COP31 - but Idealism and Ambition Must Not Outpace Delivery, Says APM
LONDON--(BUSINESS WIRE)--UK business leaders are optimistic about the approaching UN climate change conference COP31 (taking place 9 to 20 November in Antalya, Turkey) with 88% confident that November’s conference will lead to meaningful global action, but the same proportion (88%) also anticipate the conference will require their business to implement changes. Association for Project Management (APM), which carried out a survey - with Censuswide - of 307 CEOs and senior directors, says that un...
-
Merck Initiates Phase 3 Study Evaluating Ohtuvayre® (ensifentrine) for the Prevention of COPD Exacerbations in Adult Patients Receiving Standard of Care With a History of Exacerbations
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of ENHANCE-3 (NCT07874815), a Phase 3 randomized clinical trial evaluating OHTUVAYRE (ensifentrine) for the prevention of chronic obstructive pulmonary disease (COPD) exacerbations in adult patients receiving standard of care (SOC) with a history of exacerbations. Recruitment of the ENHANCE-3 trial has begun, and the first patients are now enrolling in the Unite...
-
Aptiv Reports Third Quarter 2026 Results
SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Aptiv PLC (NYSE: APTV) (the “Company”), a global technology company, today announced its third quarter 2026 results via an earnings release available on the Company’s Investor Relations website at https://ir.aptiv.com/financials/quarterly-results/.Management will host an investor conference call to review the results at 8:00 a.m. Eastern Time today. A link to the live webcast and presentation materials will be made available on the Aptiv Investor Relat...
-
RPX Gold Intersects 6.24 g/t Gold Over 19.68 Metres, Extending Near Surface High-Grade Gold Mineralization
TORONTO--(BUSINESS WIRE)--RPX Gold Inc. (“RPX Gold” or the “Company”) (TSXV: RPX) (OTCQB: RDEXF) is pleased to announce the extension of high-grade gold mineralization with open pit potential originally identified in the 2026 Preliminary Economic Assessment (“PEA”). This extension was determined via its ongoing 2026 drilling program at the Wawa Gold Project (the “Project”) in Ontario, which returned assay results from eleven (11) drill holes totalling 1,845 metres (“m”). The Company continues t...
-
Pfizer Reports Strong Third-Quarter 2026 Results And Raises 2026 Guidance
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for the third quarter of 2026 and raised its full-year 2026 guidance(2) for both Revenues and Adjusted(3) diluted EPS. EXECUTIVE COMMENTARY Dr. Albert Bourla, Chairman and CEO of Pfizer: "Pfizer had another strong quarter with commercial momentum and disciplined execution while advancing our strategy for creating long-term shareholder value. Our obesity program continued to advance and recent milestones in oncology, i...
-
Pfizer Appoints Cecile Guegan as Chief Financial Officer
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its Board of Directors has unanimously appointed Cecile Guegan as Chief Financial Officer and Executive Vice President, effective November 1, 2026. Cecile has served as interim Chief Financial Officer since August 16, 2026, steering the company’s financial operations, execution and strategic planning. “Cecile is an exceptional finance leader who knows our company and industry deeply, and she has a proven track record of opt...
-
Kbrw et Accenture accompagnent Orange pour moderniser l’exécution de ses commandes et améliorer l’expérience client
PARIS--(BUSINESS WIRE)--Kbrw, spécialiste de l’orchestration et de l’exécution des flux supply chain, et Accenture (NYSE : ACN) ont été choisis par Orange pour transformer la gestion de ses commandes clients et de ses stocks sur ses canaux en ligne, dans ses boutiques et dans ses activités B2B. Ensemble, Kbrw et Accenture accompagnent Orange dans la mise en place d’un processus d’exécution des commandes plus fluide et plus réactif, au bénéfice de ses clients. La première phase du programme de d...
-
Eaton Reports Record Third Quarter 2026 Results, with Strong Organic Growth, Accelerating Record Orders and Backlog; Raises Organic Growth Guidance
DUBLIN--(BUSINESS WIRE)--Intelligent power management company Eaton Corporation plc (NYSE:ETN) today reported strong third quarter 2026 results, including earnings per share of $2.77. Adjusted earnings per share were a record of $3.68, excluding charges of $0.62 per share related to intangible amortization, $0.30 per share related to acquisitions and divestitures, and income of $0.01 per share related to a multi-year restructuring program. Sales in the quarter were a record $8.9 billion, up 28%...